Truecheck Diabetes  from Datar Cancer Genetics is a revolutionary multi cancer screening test, based on a simple blood draw, for early detection of six type of urinary tract cancer and gastrointestinal cancer which are more common in asymptomatic individuals who have diabetes.

Individuals with Type 2 diabetes are twice as likely to be diagnosed with pancreatic cancer or liver cancer as compared to those without Type 2 diabetes. These individuals are also at a higher risk of other cancers such as gallbladder cancer, kidney cancer, bladder cancer and colorectal cancer. These risks have prompted physicians to consider the value of cancer screening for people with diabetes. Studies have shown that early detection of cancer improves survival rates.

Trucheck™ – Diabetes is totally non-invasive, radiation free and can be availed from the comfort of your office or home. Trucheck™ – Diabetes is intended to be performed annually as a routine test.